KLK3 and adenocarcinoma: The patient’s prostate-specific antigen (PSA) level was 21 ng/mL (reference range: 0-4 ng/mL), and transrectal ultrasound-guided biopsy revealed a Gleason score of 3+4 adenocarcinoma with a clinical stage of cT2b.